Optimization of Drug Treatment in Hospitalized Elderly (OMAGE)

Not Applicable

Completed

• Conditions: Global Medical Assessment of Elderly Frail Patients
• Interventions: Procedure: drug - oriented multifaceted intervention

• Registration Number: NCT00450034
• Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Brief Summary

A randomized trial has been designed to determine if this complex intervention can significantly decrease the risk of unplanned readmissions in this very elderly population, compared with usual care.

Detailed Description

Drug treatment in elderly is not yet optimal. 20 to 30% of admissions of elderly aged over 80 are related to drug problems, most of them being preventable. To decrease drug related hospitalizations need iatrogenic prevention, compliance improvement, and underuse decrease. A multifaceted intervention has been designed, included three dimensions : 1/ drug optimization 2/ patient and/or caregiver education and 3/ better coordination with home health professionals before discharge.

A randomized trial has been designed to determine if this complex intervention can significantly decrease the risk of unplanned readmissions in this very elderly population, compared with usual care.

Study Timeline

• Status Verified: 2007-03
• Study First Submitted: 2007-03-19
• Study First Submitted QC: 2007-03-19
• Study First Posted: 2007-03-21
• Study Start: 2007-04
• Primary Completion: 2009-06
• Study Completion: 2009-06
• Last Update Submitted: 2011-11-30
• Last Update Posted: 2011-12-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 665

Inclusion Criteria

• Patients hospitalized as a matter of urgency in unity(unit) of geriatrics acute
• Patients of more than 70 years old
• Hospitalization in the Unity(Unit) of Geriatrics foreseen(planned) superior acute in 5 days
• enlightened assent writing and signed
• preliminary medical examination

Read More

Exclusion Criteria

• Patients in scheduled(programmed) hospitalization
• Patient in palliative care
• Patient whose vital forecast is engaged(opened) in 3 months
• Patient already include during a previous hospitalization Patient already included in a study concerning the therapeutic care
• Followed medical impossible (refusal of care, absence of alive regular, patient doctor abroad)
• not membership to a regime of Social Security or CMU
• Patient not speaking French

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1	drug - oriented multifaceted intervention	-

Primary Outcome Measures

Name	Time	Method
Rate of unplanned readmissions, including emergency consultations,	during the study

Secondary Outcome Measures

Name	Time	Method
Mortality at 6 months,	at 6 months
delay before readmission,	before readmission
number of drug events related readmissions.	readmissions
Data collected at 3 and 6 months	at 3 and 6 months

Trial Locations

Locations (1)

Chu Bichat Claude Bernard; 🇫🇷 Paris, France